Healthcare -
Biotechnology - NASDAQ - US
$ 10.86
3.23 %
$ 440 M
Market Cap
-2.08
P/E
KROS - GROSS PROFIT
Gross Profit KROS - Keros Therapeutics, Inc.
-664 K
LAST VALUE
-1.71%
2 YEAR CAGR
-43.01%
5 YEAR CAGR
0.00%
10 YEAR CAGR